Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
Negative citations; cardiac stem cell saga continues; identifying anonymized genomic study participants; evolution of allergens; a call for biodefense innovation